ACP Journal Club. Anti-TNFalpha therapy did not increase short- or medium-term risk for cancer in patients with rheumatoid arthritis
- PMID: 20479018
- DOI: 10.7326/0003-4819-152-10-201005180-02013
ACP Journal Club. Anti-TNFalpha therapy did not increase short- or medium-term risk for cancer in patients with rheumatoid arthritis
Comment on
-
Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?Arthritis Rheum. 2009 Nov;60(11):3180-9. doi: 10.1002/art.24941. Arthritis Rheum. 2009. PMID: 19877027
Publication types
LinkOut - more resources
Full Text Sources